May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Interferon–Gamma Polymorphisms as Genetic Predictors of Uveitis in Sarcoidosis
Author Affiliations & Notes
  • S.R. J. Taylor
    Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom
  • V. Menezo
    Clinical Ophthalmology, Moorfields Eye Hospital & Institute of Ophthalmology, London, United Kingdom
  • P.A. Lympany
    Department of Occupational and Environmental Medicine, Imperial College of Science, Technology and Medicine, London, United Kingdom
  • D. Watson
    Clinical Ophthalmology, Institute of Ophthalmology, London, United Kingdom
  • R.M. du Bois
    Department of Occupational and Environmental Medicine, Imperial College of Science, Technology and Medicine, London, United Kingdom
  • S. Lightman
    Clinical Ophthalmology, Moorfields Eye Hospital & Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships  S.R.J. Taylor, None; V. Menezo, None; P.A. Lympany, None; D. Watson, None; R.M. du Bois, None; S. Lightman, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3718. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.R. J. Taylor, V. Menezo, P.A. Lympany, D. Watson, R.M. du Bois, S. Lightman; Interferon–Gamma Polymorphisms as Genetic Predictors of Uveitis in Sarcoidosis . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3718.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Cytokines are known to play an important role in the pathogenesis and disease progression of sarcoidosis and high levels of Interferon–Gamma have been found in patients with pulmonary disease. The aim of this study was to determine if any correlation exists between Interferon–Gamma (IFN–γ) and Interferon–Gamma Receptor 1 (IFN–γ–R1) polymorphisms and associated uveitic involvement in patients with sarcoidosis. Methods: 120 UK Caucasian patients with systemic sarcoidosis were identified and subdivided into 2 categories: 39 with associated uveitis and 81 without; 55 age–matched patients with idiopathic uveitis were used as a control. Total genomic DNA from peripheral citrated blood was extracted using a salt extraction method and four separate IFN–γ and two separate IFN–γ–R1 polymorphisms were identified using TaqMan PCR. Results: We compared the phenotype, genotype and allele distributions of each of the groups for each of the six polymorphisms in turn, looking for statistically significant differences. We found a significant difference in the frequency of IFN–γ (–4925) C/T genotype in the group of patients with systemic sarcoidosis and associated uveitis compared to those without eye involvement (95% vs. 80%, p = 0.01). There was a trend in the genotype frequency of IFN–γ (–2671) T/C and IFN–γ (–2459) A/G in patients with sarcoidosis and inflammatory eye disease compared to those with no eye involvement [(77% vs. 70%, p = 0.07) and (82% vs. 72%, p = 0.09) respectively]. Conclusion: In this preliminary study we found a statistically significant difference between phenotype and the IFN–γ (–4925) C/T genotype, and a trend in the distribution of the IFN–γ (–2671) T/C and IFN–γ (–2459) A/G genotypes. This limited success may represent the relatively small number of known IFN–γ and IFN–γ–R1 polymorphisms that were examined, the influence of cytokines such as IL–12 and IL–18 on IFN–γ production rather than intrinsic IFN–γ polymorphisms or may represent the fact that the groups of patients examined were at different stages of disease progression. These possible explanations provide direction for further study.

Keywords: uveitis–clinical/animal model • cytokines/chemokines • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×